| Literature DB >> 20122255 |
Amitabh Sharma1, Sreenivas Chavali, Rubina Tabassum, Nikhil Tandon, Dwaipayan Bharadwaj.
Abstract
BACKGROUND: Identification of disease genes for Type 2 Diabetes (T2D) by traditional methods has yielded limited success. Based on our previous observation that T2D may result from disturbed protein-protein interactions affected through disrupting modular domain interactions, here we have designed an approach to rank the candidates in the T2D linked genomic regions as plausible disease genes.Entities:
Mesh:
Year: 2010 PMID: 20122255 PMCID: PMC2824729 DOI: 10.1186/1471-2164-11-84
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Elucidation of the components used for the ranking the positional candidates in T2D.
Gene ontologies revealed by BiNGO for ranked positional candidates
| GO ID | Gene ontology - description | No. of ranked candidates | p-value |
|---|---|---|---|
| GO:0008151 | Cellular process | 279 | 1.3 × 10-3 |
| GO:0008152 | Metabolic process | 237 | 1.8 × 10-12 |
| GO:0044237 | Primary metabolic process | 225 | 3.6 × 10-13 |
| GO:0044238 | Cellular metabolic process | 250 | 1.5 × 10-13 |
| GO:0043170 | Macromolecule metabolic process | 198 | 1.7 × 10-10 |
| GO:0019358 | Protein metabolic process | 160 | 1.2 × 10-28 |
| GO:0044260 | Cellular macromolecule metabolic process | 159 | 2.0 × 10-30 |
| GO:0044267 | Cellular protein metabolic process | 158 | 1.3 × 10-30 |
| GO:0043283 | Biopolymer metabolic process | 144 | 4.1 × 10-5 |
| GO:0065007 | Biological regulation | 138 | 4.3 × 10-3 |
| GO:0050791 | Regulation of biological process | 118 | 0.018 |
| GO:0051244 | Regulation of cellular process | 108 | 0.04 |
| GO:0007154 | Cell communication | 106 | 0.026 |
| GO:0006464 | Protein modification process | 100 | 4.9 × 10-22 |
| GO:0043412 | Biopolymer modification | 100 | 5.4 × 10-21 |
| GO:0007165 | Signal transduction | 97 | 0.036 |
| GO:0043687 | Post-translational protein modification | 96 | 2.1 × 10-25 |
| GO:0006796 | Phosphate metabolic process | 85 | 2.0 × 10-30 |
| GO:0006793 | Phosphorus metabolic process | 85 | 5.0 × 10-30 |
| GO:0016310 | Phosphorylation | 84 | 5.3 × 10-36 |
| GO:0006468 | Protein amino acid phosphorylation | 83 | 2.3 × 10-41 |
| GO:0051869 | Response to stimulus | 77 | 4.5 × 10-3 |
| GO:0007242 | Intracellular signaling cascade | 55 | 2.2 × 10-4 |
| GO:0006950 | Response to stress | 50 | 1.5 × 10-7 |
| GO:0051242 | Positive regulation of cellular process | 38 | 7.5 × 10-4 |
| GO:0002376 | Immune system process | 31 | 0.011 |
| GO:0007243 | Protein kinase cascade | 27 | 0.017 |
| GO:0006629 | Lipid metabolic process | 20 | 0.027 |
| GO:0012501 | Programmed cell death | 27 | 0.034 |
| GO:0006954 | Inflammatory response | 23 | 3.4 × 10-6 |
Top thirty biological processes enriched by 435 ranked positional candidates
Performance comparison of different methods using benchmarking dataset
| Wv | HRC | PROSPECTR | SUSPECTS | G2D | DGP | |
|---|---|---|---|---|---|---|
| Accuracy (%) | 94.9 | 41.4 | 61.1 | 72.8 | 49.8 | |
| Sensitivity (%) | 73.7 | 31.6 | 52.6 | 52.6 | 58.8 | |
| Specificity (%) | 96 | 38.8 | 61.5 | 73.9 | 49.3 |
Numbers in bold letters indicate significant values
Figure 2Rank ROC curve obtained for disease validation. (A) Weight value method. (B) HWEc method. Red symbols and Blue line: Fitted ROC curve. Gray lines: 95% confidence interval of the fitted ROC curve.
Comparison with GeneWanderer (Random walk) method
| Gene | Wv | HRC | Prioritized- Wv + HRC | Ranking by GeneWanderer Random walk method |
|---|---|---|---|---|
| 35 | ||||
| 1 | - | |||
| 0.667 | ||||
| 0.033 | 4 | |||
| 16 | ||||
| 30 | ||||
| 71 | ||||
| 0.286 | 41 | |||
| 0.016 | ||||
| 0.016 | ||||
| 0.053 | 16 | |||
| 0.48 | 0.03 | - | ||
| 0.46 | 21 | |||
| 0.44 | ||||
| 0.37 | 0.055 | 42 | ||
| 0.21 | 0.067 | |||
| 0 | - |
The bold letters highlight significant values; Dataset comprised recently identified disease genes in T2D